Plenary
Indicates that handouts are available
Saturday, March 1, 2014
8:15 AM-9:45 AM
2101
Immunotherapy: Mechanism, Outcomes and Markers
Session Details
Saturday, March 1, 2014: 8:15 AM-9:45 AM
Convention Center, Ground Level, Exhibit Hall A
1.50 CME/ 1.80 CE
Moderator:
Linda Cox , MD FAAAAI
Learning Objectives:
- Discuss the benefits of specific immunotherapy
- Describe factors affecting safety of specific allergy immunotherapy
- Discuss the use of biomarkers to predict the response to immunotherapy to pollens
8:15 AM
Tolerance to Allergens: How it Develops and How it Can be Induced
Cezmi A. Akdis, MD FAAAAI
8:45 AM
Biomarker Predictors of Effective Immunotherapy
Stephen R. Durham, MA MD FRCP
9:15 AM
SIT Outcomes: Examining the Data for Efficacy, Safety, Adherence and Costs
Linda Cox, MD FAAAAI
Sunday, March 2, 2014
8:15 AM-9:45 AM
3101
Integrated Airways
Session Details
Sunday, March 2, 2014: 8:15 AM-9:45 AM
Convention Center, Ground Level, Exhibit Hall A
1.50 CME/ 1.80 CE
Moderator:
Steve N. Georas , MD
Learning Objectives:
- Discuss the immunopathogenesis of barrier dysfunction in chronic rhinosinusitis
- Describe the relationship between barrier dysfunction and the immunopathogenesis of asthma
- Discuss how asthma endotypes are influencing the development of personalized asthma therapy
8:15 AM
Host Defense, Inflammation and Remodeling in the Upper Airway
Robert P. Schleimer, PhD FAAAAI
8:45 AM
Barrier Dysfunction in the Lower Airway
Donna Davies, BSc PhD
9:15 AM
Asthma Endotypes: The Next Step Towards Personalized Asthma Care
Sally E. Wenzel, MD FAAAAI
Monday, March 3, 2014
8:15 AM-9:45 AM
4101
Drug Allergy in the 21st Century
Session Details
Monday, March 3, 2014: 8:15 AM-9:45 AM
Convention Center, Ground Level, Exhibit Hall A
1.50 CME/ 1.80 CE
Moderator:
David A. Khan , MD FAAAAI
Learning Objectives:
- Discuss the genetic basis for selected drug reactions
- Recognize and interpret erythematous drug eruptions
- Develop expertise in the management of hypersensitivity reactions to chemotherapy, monoclonals, new biologicals and antibiotics
8:15 AM
HLA and Drug Hypersensitivity
David A. Ostrov, PhD
8:45 AM
Exanthematous Drug Eruptions
Werner J. Pichler, MD
9:15 AM
New Challenges and Outcomes for Drug Desensitization
Mariana C. Castells, MD PhD FAAAAI
Tuesday, March 4, 2014
8:15 AM-9:45 AM
5101
Bioaerosols: When Not to Take a Deep Breath at Work
Session Details
Tuesday, March 4, 2014: 8:15 AM-9:45 AM
Convention Center, Ground Level, Exhibit Hall A
1.50 CME/ 1.80 CE
Moderator:
Leslie C. Grammer , MD FAAAAI
Learning Objectives:
- State the health effects of bioaerosol exposure on health in office building workers
- Discuss the immunologic mechanisms of respiratory disease associated with working in large animal confinement feeding operations
- Describe bioaerosol sampling methods and exposure risk for health effects in textile manufacturing workers
8:15 AM
Office: Building - Related Illness
Jean M. Cox-Ganser, PhD
8:45 AM
Agriculture: Respiratory Illness in Large Animal Farming Environments
Jill A. Poole, MD FAAAAI
9:15 AM
Factory: Occupational Illness in the Textile Industry
David C. Christiani, MD
![[ Visit Client Website ]](images/banner.jpg)